Allergies
New allergies study findings have been published by J. Hay and colleagues
Published in Respiratory Therapeutics Week, February 22nd, 2010
"This study evaluates the costs and utilization burden associated with oral, branded second-generation antihistamines (BSGAs) compared with montelukast (MTLK) as first-choice treatment in newly diagnosed allergic rhinitis (AR) patients without asthma. We compared annual medical costs of illness and utilization changes from 1 year before index AR diagnosis to I year after for continuously enrolled AR patients initiating therapy with BSGA or MTLK," scientists writing in the journal Allergy and Asthma Proceedings report.
"Multivariate regressions for each outcome variable adjusted for confounders including age, sex, geographic region, Charlson Comorbidity Index,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Respiratory Therapeutics Week
More Articles from Respiratory Therapeutics Week
- Imperial College London
Blood clotting finding may lead to new treatments - JAMA and Archives Journals
Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer - Allergies
Data on allergies published by D.V. Wallace and colleagues - Allergies
New findings reported from B.E. Chipps and co-authors describe advances in allergies - Allergies
Recent studies by D. Bukstein and co-authors add new data to allergies findings - Asthma
New findings from T. Ahmad and co-authors in the area of asthma published - More from this issue of Respiratory Therapeutics Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
